Washington [US], September 15 (ANI): For more than a decade, drugs like enzalutamide, which prevent male hormones from activating the androgen receptor, have been used to treat metastatic prostate cancer. While these treatments are generally effective, they can eventually stop working, but there is little knowledge of how this happens.
\
\
